Quipt Home Medical (QIPT) to Release Earnings on Monday

Quipt Home Medical (NASDAQ:QIPT) is projected to release its Q4 2025 results before the market opens on Monday, December 15th. Analysts expect Quipt Home Medical to post earnings of $0.03 per share and revenue of $87.4620 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, December 16, 2025 at 4:00 PM ET.

Quipt Home Medical Stock Performance

QIPT stock opened at $2.43 on Monday. Quipt Home Medical has a 1 year low of $1.35 and a 1 year high of $3.27. The stock has a market capitalization of $105.56 million, a price-to-earnings ratio of -10.12 and a beta of 0.59. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.75 and a current ratio of 1.15. The stock’s fifty day moving average is $2.44 and its two-hundred day moving average is $2.27.

Institutional Trading of Quipt Home Medical

Institutional investors have recently made changes to their positions in the stock. Kanen Wealth Management LLC increased its stake in shares of Quipt Home Medical by 108.4% during the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company’s stock valued at $6,919,000 after acquiring an additional 1,544,529 shares during the period. Vanguard Group Inc. acquired a new stake in Quipt Home Medical in the third quarter worth approximately $4,539,000. Franklin Resources Inc. boosted its stake in Quipt Home Medical by 8.6% during the 3rd quarter. Franklin Resources Inc. now owns 895,398 shares of the company’s stock valued at $2,337,000 after purchasing an additional 71,274 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in Quipt Home Medical by 19.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 752,743 shares of the company’s stock valued at $1,964,000 after purchasing an additional 121,631 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in shares of Quipt Home Medical by 4.7% during the 3rd quarter. Russell Investments Group Ltd. now owns 594,590 shares of the company’s stock valued at $1,552,000 after purchasing an additional 26,501 shares during the period. 42.85% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Quipt Home Medical from a “sell” rating to a “hold” rating in a report on Saturday, August 16th. Canaccord Genuity Group raised their price target on shares of Quipt Home Medical from $1.70 to $2.30 and gave the company a “hold” rating in a research note on Tuesday, August 19th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quipt Home Medical in a report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $3.15.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.